Healthcare Success

  Overview of This Study: The study involved four major activities in estimating the current size of the transplant diagnostics market. Exhaustive secondary research was conducted to collect information on the market and its different subsegments. Download PDF Brochure @ https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=2531061 The growth of this market is mainly driven by increasing number of transplantation procedures, technological advancements in transplant diagnostics, increasing public and private funding for targeted research activities, and increasing burden on infectious diseases driving growth of transplant diagnostics market. Recent Developments in Transplant Diagnostics Market ·          In August 2019, Care Dx (US) acquired XynManagement (US) to simplify transplant quality tracking and waitlist management. ·          In March 2019, Hologic established a learning and experi...

  The transplant diagnostics market is projected to reach USD 5.5 billion by 2025 from USD 3.6 billion in 2019, at a CAGR of 7.2%. The growth of this market is primarily driven by the increasing number of transplantation procedures, technological advancements in the field of transplant diagnostics, increasing public-private funding for target research activities, and growing burden of infectious diseases are driving the growth of the transplant diagnostics market. These factors have prompted market players to improve and strengthen their current manufacturing and distribution capabilities—especially in emerging markets, which are expected to witness the highest growth. Some prominent players in the transplant diagnostics market are Thermo Fisher Scientific Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffman-La Roche Ltd. (Switzerland), QIAGEN N.V. (Netherlands), and Immucor, Inc. (US). An analysis of the developments in the transplant diagnostics market from 2016–2019 showed tha...